journal article·2023-10

Molecular simulation of Cu, Ag, and Au-decorated Molybdenum doped graphene nanoflakes as biosensor for carmustine, an anticancer drug

Chioma M. Chima, Hitler Louis, Destiny Charlie, Ann Imojara, Innocent Benjamin, Emmanuel E. Uzowuru, Adedapo S. Adeyinka

Publisher page

Abstract

This study delves into the fascinating realm of molybdenum-doped graphene (Mo@GP) complexes, featuring captivating adsorption sites for oxygen (O) and chlorine (Cl), adorned with the mesmerizing presence of silver (Ag), gold (Au), and copper (Cu). These alluring metal-doped compounds have been proposed as potential biosensor materials, with a particular focus on their prowess in the adsorption of carmustine (cmt). Employing the formidable density functional theory (DFT) at the B3LYP-GD3BJ/def2-SVP computational approach. Enveloped by the intrigue of two distinct adsorption sites—O and Cl—we stumbled upon a remarkable revelation. Among the contenders, Cl_cmt@Ag_Mo@GP emerged triumphant with the lowest energy gap at the Cl site of carmustine adsorption, an astonishingly meager value of 0.082 eV. Following closely behind, Cl_cmt@Au_Mo@GP boasted a respectable energy gap of 0.852 eV. However, Cl_cmt@Cu_Mo@GP and Cl_cmt@Mo@GP took the stage with their grandiose energy gaps, exhibiting values of 1.128 eV and 1.843 eV, respectively. Substantially, the captivating saga unfolds, presenting the distribution of adsorption energies as follows: Cl_cmt@Mo@GP > O_cmt@Mo@GP > Cl_cmt@Au_Mo@GP > Cl_cmt@Cu_Mo@GP > O_cmt@Cu_Mo@GP > Cl_cmt@Ag_Mo@GP. In a captivating interplay of energies, the system Ag_Mo@GP unveils its preferences: the O site reigns supreme with an Eads of -0.59 eV, while the Cl site humbly follows with an Eads of -0.03. Meanwhile, within the realm of the Au_Mo@GP system, the Chlorine site claims dominance, boasting an Eads of -1.30eV, while the Oxygen site asserts its presence with an Eads of -0.21 eV. As for the Cu_Mo@GP system, the Chlorine site emerges as the epitome of favorability, commanding an Eads of -0.83 eV, while the Oxygen site modestly exhibits an Eads of -0.29 eV. Through meticulous exploration, the results unequivocally demonstrate the remarkable qualities of the investigated complexes, positioning them as promising nanomaterials for the realm of drug delivery.
Source: expertdata · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Advanced biosensing and bioanalysis techniques · Molecular Junctions and Nanostructures · Nanomaterials for catalytic reactions

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (72)

Show source-provided references
1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2. Overcome treatment-resistance in breast cancer cells
3. The matrix in cancer10.1038/s41568-020-00329-7 ↗
4. Effect of tumor microenvironment on pathogenesis of the head and neck squamous cell carcinoma: a systematic review10.1186/s12943-019-0983-5 ↗
5. Economic burden and treatment patterns for patients with diffuse large B-cell lymphoma and follicular lymphoma in the USA10.2217/cer-2018-0094 ↗
6. From chemotherapy to biological therapy: a review of novel concepts to reduce the side effects of systemic cancer treatment10.3892/ijo.2018.4661 ↗
7. A numerical study of the distribution of chemotherapeutic drug carmustine in brain glioblastoma
8. Potential use of nitrogen-doped carbon nanotube sponges as payload carriers against malignant glioma10.3390/nano11051244 ↗
9. Nanogels as a versatile drug delivery system for brain cancer10.3390/gels7020063 ↗
10. A review on allopathic and herbal nanofibrous drug delivery vehicles for cancer treatments
11. Theoretical study of the tautomerization of Carmustine in a biological media as an anti-cancer drug
12. Drug delivery by SiC nanotubes as nanocarriers for anti-cancer drugs: investigation of drug encapsulation and system stability using molecular dynamics simulation10.1088/2053-1591/ac3107 ↗
13. Computational investigation of the carmustine (BCNU) alkylation mechanism using the QTAIM, IQA, and NBO models10.1007/s11224-020-01604-x ↗
14. DFT and MD investigations on the functionalized boron nitride nanotube as an effective drug delivery carrier for Carmustine anticancer drug10.1016/j.molliq.2018.12.028 ↗
15. Assessment of solvent effects on the interaction of Carmustine drug with the pristine and COOH-functionalized single-walled carbon nanotubes: a DFT perspective10.1016/j.molliq.2017.05.035 ↗
16. Comprehensive theoretical prediction of the stability and electronic properties of hydroxyurea and carmustine drugs on pristine and Chitosan-functionalized graphitic carbon nitride in vacuum and aqueous environment10.1016/j.vacuum.2022.111565 ↗
17. Applications of diatoms and silica nanotechnology in biosensing, drug and gene delivery, and formation of complex metal nanostructures10.1016/j.trac.2011.04.015 ↗
18. Review on conducting polymers and their applications10.1080/03602559.2012.710697 ↗
19. Nano-engineered tools in the diagnosis, therapeutics, prevention, and mitigation of SARS-CoV-210.1016/j.jconrel.2021.08.046 ↗
20. Sulfur mustard gas adsorption on ZnO fullerene-like nanocage: quantum chemical calculations10.1016/j.spmi.2017.03.046 ↗
21. Investigations of adsorption behavior and anti-cancer activity of curcumin on pure and platinum-functionalized B12N12 nanocages10.1016/j.molliq.2021.116516 ↗
22. Electrospinning synthesis of transition metal alloy nanoparticles encapsulated in nitrogen-doped carbon layers as an advanced bifunctional oxygen electrode10.1039/D0TA00826E ↗
23. Transition metal and nitrogen Co‐doped carbon‐based electrocatalysts for the oxygen reduction reaction: from active site insights to the rational design of precursors and structures10.1002/cssc.202002137 ↗
24. Shenoy · 2022
25. Structural, magnetic, and antimicrobial properties of zinc doped magnesium ferrite for drug delivery applications10.1016/j.ceramint.2019.10.243 ↗
26. Effects of B and N doping/codoping on the adsorption behavior of C60 fullerene towards aspirin: a DFT investigation10.1016/j.molliq.2021.117459 ↗
27. Frisch · 2016
28. Dennington · 2016
29. On Koopmans' theorem in density functional theory10.1063/1.3491272 ↗
30. VMD: visual molecular dynamics10.1016/0263-7855(96)00018-5 ↗
31. Multiwfn: a multifunctional wavefunction analyzer10.1002/jcc.22885 ↗
32. Nwobodo · 2023
33. Dikomang · 2019
34. Facile synthesis of 5-aryl-N-(pyrazin-2-yl) thiophene-2-carboxamides via suzuki cross-coupling reactions, their electronic and nonlinear optical properties through DFT calculations10.3390/molecules26237309 ↗
35. Synthesis, computational and molecular docking study of some 2, 3-dihydrobenzofuran and its derivatives10.1016/j.molstruc.2020.129225 ↗
36. Quantum mechanical and spectroscopic (FT-IR, FT-Raman) study, NBO analysis, HOMO-LUMO, first order hyperpolarizability and molecular docking study of methyl [(3R)-3-(2-methylphenoxy)-3-phenylpropyl] amine by density functional method10.1016/j.saa.2017.07.029 ↗
37. E)-2-((3-nitrophenyl) diazenyl)-3-oxo-3-phenylpropanal: experimental, DFT studies, and molecular docking investigations
38. Modelling of aminothiophene-carbonitrile derivatives as potential drug candidates for hepatitis B and C10.1007/s40995-022-01355-w ↗
39. Hydrogen storage capacity of C12X12 (X= N, P, and Si)10.1016/j.chphi.2022.100107 ↗
40. Computational study on the interactions of functionalized C24NC (NC= C,–OH,–NH2,–COOH, and B) with chloroethylphenylbutanoic acid
41. Synthesis, spectroscopic, DFT study, and molecular modeling of thiophene-carbonitrile against enoyl-ACP reductase receptor
42. Therapeutic potential of B12N12-X (X= Au, Os, and Pt) nanostructured as effective fluorouracil (5Fu) drug delivery materials10.1021/acsabm.2c00986 ↗
43. Heteroatoms (B, N, S) doped quantum dots as potential drug delivery system for isoniazid: insight from DFT, NCI, and QTAIM10.1016/j.heliyon.2022.e12599 ↗
44. Density functional theory (DFT) computation of pristine and metal-doped MC59 (M= Au, Hf, Hg, Ir) fullerenes as nitrosourea drug delivery systems10.1016/j.mssp.2023.107362 ↗
45. Transition metal-decorated B12N12–X (X= Au, Cu, Ni, Os, Pt, and Zn) nanoclusters as biosensors for carboplatin10.1021/acsomega.2c07250 ↗
46. Heteroatom (B, N, P, and S)-doped cyclodextrin as a hydroxyurea (HU) drug nanocarrier: a computational approach10.1021/acsomega.2c06630 ↗
47. Investigation on the molecular, electronic, biological and spectroscopic properties of a novel cobalt complex: an intuition from an experimental and computational perspective10.1016/j.poly.2023.116369 ↗
48. Adsorption properties of metal functionalized fullerene (C59Au, C59Hf, C59Ag, and C59Ir) nanoclusters for application as a biosensor for hydroxyurea (HXU): insight from theoretical computation10.1515/zpch-2022-0126 ↗
49. Anti-hypertensive properties of 2-[N-(4-methylbenzenesulfonyl)-1-phenylformamido]-n-(4-nitrophenyl)-3-phenylpropenamide: experimental and theoretical studies10.1016/j.chphi.2022.100158 ↗
50. Synthesis, characterization and theoretical investigations on the molecular structure, electronic property and anti-trypanosomal activity of benzenesulphonamide-based carboxamide and its derivatives
51. Crystal structure analysis, magnetic measurement, DFT studies, and adsorption properties of novel 1-(2, 5-dimethyphenyl) piperazine tetrachlorocobaltate hydrate
52. Gannouni · 2023 · 1
53. Trapping of dichlorosilane (H2SiCl2) gas by transition metals doped fullerene nanostructured materials10.1016/j.jics.2023.100940 ↗
54. Hydrazineylidene‐3‐oxopropanal derivatives as antiviral agents for treatment of HBV and HCV: experimental, DFT, and molecular docking studies10.1002/vjch.202200063 ↗
55. Systematic exo-endo encapsulation of hydroxyurea (HU) by Cu, Ag, and Au-doped gallium nitride nanotubes (GaNNT) for smart therapeutic delivery10.1016/j.compbiomed.2023.106934 ↗
56. Functionalized (-HCO,-OH,-NH2) iridium-doped graphene (Ir@ Gp) nanomaterials for enhanced delivery of piroxicam: insights from quantum chemical calculations10.1016/j.molliq.2023.122068 ↗
57. Computational study on nickel doped encapsulated Mg, K, Ca on pristine C24 nanocage for gas sensing applications10.1016/j.mssp.2023.107334 ↗
58. Complementarity of QTAIM and MO theory in the study of bonding in donor–acceptor complexes10.1016/j.ccr.2004.08.022 ↗
59. On the connections between the quantum theory of atoms in molecules (QTAIM) and density functional theory (DFT): a letter from Richard FW Bader to Lou Massa10.1007/s11224-017-0946-7 ↗
60. Philosophical aspects and implications of the quantum theory of atoms in molecules (QTAIM)10.1007/s10698-013-9194-0 ↗
61. Beyond the orthodox QTAIM: motivations, current status, prospects and challenges10.1007/s10698-012-9170-0 ↗
62. On bond-critical points in QTAIM and weak interactions10.1007/s00894-018-3684-x ↗
63. Revealing non-covalent interactions in solids: NCI plots revisited10.1039/c2cp41395g ↗
64. Revealing non‐covalent interactions in molecular crystals through their experimental electron densities10.1002/chem.201201290 ↗
65. Scaling relations between adsorption energies for computational screening and design of catalysts10.1039/C4CY00335G ↗
66. CO adsorption energies on metals with correction for high coordination adsorption sites–A density functional study10.1016/j.susc.2007.01.052 ↗
67. Insight into the design of defect electrocatalysts: from electronic structure to adsorption energy10.1016/j.mattod.2019.05.021 ↗
68. Insight into the design of defect electrocatalysts: from electronic structure to adsorption energy10.1016/j.mattod.2019.05.021 ↗
69. Adsorption-energy-based activity descriptors for electrocatalysts in energy storage applications10.1093/nsr/nwx119 ↗
70. Molecular thermodynamics of hydrophobic effects10.1016/S1359-0294(97)80041-6 ↗
71. Accounting for the unique, doubly dual nature of ionic liquids from a molecular thermodynamic and modeling standpoint10.1021/ar7000556 ↗
72. Molecular thermodynamics of chemical reactions10.1021/ie51403a008 ↗